EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Elephas is a platform that predicts response to immunotherapy by integrating instruments, reagents, processes, and software to assess a tumor's response to immunotherapy.
No recent news for this company.
Elephas Biosciences Secures $40M Series B-2 Funding to Advance Live Tumor Profiling Platform